financetom
Business
financetom
/
Business
/
Ansys posts lower-than-expected quarterly profit, revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ansys posts lower-than-expected quarterly profit, revenue
May 25, 2025 10:26 PM

April 30 (Reuters) - Ansys ( ANSS ) reported

first-quarter revenue below Wall Street estimates on Wednesday,

impacted by weak enterprise spending for its simulation software

amid an uncertain economy.

Shares of the Pennsylvania-based company fell 5% after the

bell.

The uncertainty has led to businesses cutting back on

spending and U.S. export restrictions on China weighing on the

demand for companies like Ansys ( ANSS ).

The company, which makes software used in creating products

from airplanes to tennis rackets, is being bought by larger

rival Synopsys ( SNPS ) and the deal is expected to close in the

first half of 2025.

Ansys ( ANSS ) posted revenue of $504.9 million for the quarter ended

March 31, below analysts' estimates of $520.9 million, according

to data compiled by LSEG.

On an adjusted basis, the company earned $1.64 per share,

falling short of estimates $1.68 per share.

Ansys ( ANSS ) offers AI solutions such as its customer support

chatbot AnsysGPT and a cloud-enabled product SimAI, which uses

simulation results to assess the performance of a new design in

minutes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week
BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week
May 26, 2025
08:04 AM EDT, 05/23/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) on Friday said it is presenting positive survival and clinical benefit data in three clinical poster presentations and one publish-only abstract at the American Society of Clinical Oncology (ASCO) Meeting taking place May 30 - June 3 in Chicago. We are highly encouraged by the survival and clinical...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Invivyd's Pemgarda Added to NCCN Guidelines in Oncology for B-Cell Lymphomas
Invivyd's Pemgarda Added to NCCN Guidelines in Oncology for B-Cell Lymphomas
May 26, 2025
07:35 AM EDT, 05/23/2025 (MT Newswires) -- Invivyd ( IVVD ) said Friday its investigational monoclonal antibody Pemgarda has been added to the National Comprehensive Cancer Network's clinical practice guidelines in oncology for B-cell lymphomas. The product's inclusion in the cancer non-profit's guidelines recognizes it as a potential option for pre-exposure prophylaxis against COVID-19 in patients with B-cell malignancies, the...
Indian watchdog found global ad agencies colluded on fees, document shows
Indian watchdog found global ad agencies colluded on fees, document shows
May 26, 2025
* India ad agencies, broadcasters face antitrust scrutiny * Antitrust raids in March shocked industry players * Document shows three groups indulged in alleged price fixing * Industry groups coordinate their activities, document says By Aditya Kalra NEW DELHI, May 23 (Reuters) - India's antitrust body found that global ad agencies breached laws by coordinating on commissions they charge advertisers,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved